Intest Res.  2018 Jan;16(1):43-47. 10.5217/ir.2018.16.1.43.

Quality indicators in inflammatory bowel disease

Affiliations
  • 1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Gil.Melmed@cshs.org

Abstract

Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic, debilitating, and expensive condition affecting millions of people globally. There is significant variation in the quality of care for patients with IBD across North America, Europe, and Asia; this variation suggests poor quality of care due to overuse, underuse, or misuse of health services and disparity of outcomes. Several initiatives have been developed to reduce variation in care delivery and improve processes of care, patient outcomes, and reduced healthcare costs. These initiatives include the development of quality indicator sets to standardize care across organizations, and learning health systems to enable data sharing between doctors and patients, and sharing of best practices among providers. These programs have been variably successful in improving patient outcomes and reducing healthcare utilization. Further studies are needed to demonstrate the long-term impact and applicability of these efforts in different geographic areas around the world, as regional variations in patient populations, societal preferences, and costs should inform local quality improvement efforts.

Keyword

Quality indicator, health care; Inflammatory bowel disease; Crohn disease; Colitis, ulcerative

MeSH Terms

Asia
Colitis, Ulcerative
Crohn Disease
Delivery of Health Care
Europe
Health Care Costs
Health Services Misuse
Humans
Inflammatory Bowel Diseases*
Information Dissemination
Learning
North America
Patient Care
Practice Guidelines as Topic
Quality Improvement

Cited by  3 articles

염증성 장질환 환자의 치료에 대한 주관적인 필요와 생각: Q 방법론 적용
Yong Eun Park, Jin Lee, Jongha Park, Joon Hyuk Choi, Nae Yun Heo, Seung Ha Park, Yoon Kyoung Lee, Tae Oh Kim
Korean J Gastroenterol. 2021;78(1):37-47.    doi: 10.4166/kjg.2021.053.

Improving the quality of care for inflammatory bowel disease
Byong Duk Ye, Simon Travis
Intest Res. 2019;17(1):45-53.    doi: 10.5217/ir.2018.00113.

Medication non-adherence in inflammatory bowel diseases is associated with disability
Jonathan Perry, Andy Chen, Viraj Kariyawasam, Glen Collins, Chee Choong, Wei Ling Teh, Nikola Mitrev, Friedbert Kohler, Rupert Wing Loong Leong
Intest Res. 2018;16(4):571-578.    doi: 10.5217/ir.2018.00033.


Reference

1. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008; 135:1907–1913. PMID: 18854185.
Article
2. Esrailian E, Spiegel BM, Targownik LE, Dubinsky MC, Targan SR, Gralnek IM. Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther. 2007; 26:1005–1018. PMID: 17877507.
Article
3. Spiegel BM, Ho W, Esrailian E, et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol. 2009; 7:168–174.e1. PMID: 18952199.
Article
4. Kappelman MD, Bousvaros A, Hyams J, et al. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis. 2007; 13:890–895. PMID: 17286275.
Article
5. Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008; 57:549–558. PMID: 18178610.
Article
6. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017; 112:241–258. PMID: 28071656.
Article
7. Mehta F. Report: economic implications of inflammatory bowel disease and its management. Am J Manag Care. 2016; 22(3 Suppl):s51–s60. PMID: 27269903.
8. Ahmed S, Siegel CA, Melmed GY. Implementing quality measures for inflammatory bowel disease. Curr Gastroenterol Rep. 2015; 17:14. PMID: 25762473.
Article
9. Melmed GY, Siegel CA, Spiegel BM, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013; 19:662–668. PMID: 23388547.
10. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA. 2000; 284:984–992. PMID: 10944644.
Article
11. Shekelle PG, MacLean CH, Morton SC, Wenger NS. Acove quality indicators. Ann Intern Med. 2001; 135(8 Pt 2):653–667. PMID: 11601948.
Article
12. Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003; 326:816–819. PMID: 12689983.
Article
13. Donabedian A. The role of outcomes in quality assessment and assurance. QRB Qual Rev Bull. 1992; 18:356–360. PMID: 1465293.
Article
14. Calvet X, Panés J, Alfaro N, et al. Delphi consensus statement: quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units. J Crohns Colitis. 2014; 8:240–251. PMID: 24295646.
Article
15. International Consortium for Health Outcomes Measurement (ICHOM) Web site. Inflammatory bowel disease. Accessed May 10, 2017. http://www.ichom.org/medical-conditions/inflammatory-bowel-disease/.
16. Nguyen GC, Devlin SM, Afif W, et al. Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol. 2014; 28:275–285. PMID: 24839622.
Article
17. Siegel CA, Allen JI, Melmed GY. Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013; 11:908–912. PMID: 23747710.
Article
18. Song HK, Lee KM, Jung SA, et al. Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016; 14:240–247. PMID: 27433146.
Article
19. Nguyen GC, Boland K, Afif W, et al. Modified Delphi process for the development of choosing wisely for inflammatory bowel disease. Inflamm Bowel Dis. 2017; 23:858–865. PMID: 28509817.
Article
20. Crandall W, Kappelman MD, Colletti RB, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis. 2011; 17:450–457. PMID: 20602466.
Article
21. Crandall WV, Margolis PA, Kappelman MD, et al. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012; 129:e1030–e1041. PMID: 22412030.
Article
22. Crohn's & Colitis Foundation Web site. IBD Qorus. Accessed May 10, 2017. http://www.crohnscolitisfoundation.org/science-and-professionals/ibdqorus/.
23. Tinsley A, Ehrlich OG, Hwang C, et al. Knowledge, attitudes, and beliefs regarding the role of nutrition in IBD among patients and providers. Inflamm Bowel Dis. 2016; 22:2474–2481. PMID: 27598738.
Article
24. Hou JK, Gasche C, Drazin NZ, et al. Assessment of gaps in care and the development of a care pathway for anemia in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2017; 23:35–43. PMID: 27749376.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr